title: Adjuvant arthritis pretreatment with type II collagen and Mycobacterium butyricum.
abstract: A treatment previous to adjuvant arthritis induction has been performed with type II collagen (CII) or Mycobacterium butyricum (Mb), which is the inducer of the pathology. Pretreatment was administered in two different ways: a) subcutaneously or intradermally 14 days before arthritis induction, and b) intravenously 3 days before induction. In order to relate the change in inflammation to the corresponding antigen immune response, serum antibodies and delayed type hypersensitivity (DTH) against CII or Mb were studied. Pretreatment with s.c. CII 14 days before induction produced slight protection against arthritis and significantly delayed its onset; systemic inflammation showed good positive correlation with anti-CII antibodies. The CII administered i.v. 3 days before arthritic challenge did not significantly modify the inflammatory process. The use of i.d. subarthritogenic doses of Mb 14 days before induction protected a high percentage of the animals from the posterior arthritic challenge; this protection was accompanied by high anti-Mb antibody titers and DTH reaction. When Mb was given i.v. 3 days before induction, a partial protection of inflammation was observed; arthritis was milder and its onset was delayed. These changes were accompanied by reduced humoral and cellular response to Mb.
authors.affiliation: Physiology Unit, Faculty of Pharmacy, University of Barcelona, Spain.
authors.forename: A
authors.initials: A
authors.lastname: Franch
authors.forename: S
authors.initials: S
authors.lastname: Cassany
authors.forename: C
authors.initials: C
authors.lastname: Castellote
authors.forename: M
authors.initials: M
authors.lastname: Castell
mesh_terms: D000818:Animals; D001169:Arthritis, Experimental / Q000209:etiology / Q000276:immunology / Q000517:prevention & control*; D003094:Collagen / Q000008:administration & dosage / Q000276:immunology / Q000494:pharmacology*; D005260:Female; D006968:Hypersensitivity, Delayed / Q000276:immunology; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D009170:Nontuberculous Mycobacteria / Q000276:immunology*; D051381:Rats; D017208:Rats, Wistar; D012710:Serum Albumin, Bovine / Q000633:toxicity
chemical_list: D012710:Serum Albumin, Bovine; D003094:Collagen